From: Clinical application of drug sensitive gene detection in postoperative instillation for non-muscle invasive bladder cancer
Expression level
RRM1
TOP2A
BCL-2
more than 75%
10
15
3
60–75%
6
4
40–60%
8
27
25–40%
7
2
less than 25%
17
13